EASTERN COOPERATIVE ONCOLOGY GROUP

这笔赠款的主要目标是获得资金，支持范德比尔特大学医学院东部合作肿瘤学小组(ECOG)的临床研究活动，帮助患者增加ECOG试验的应计费用，并扩大对ECOG赞助的临床试验和实验室研究的科学和行政捐款；2)进一步增加Vanderbilt研究人员对ECOG的科学和行政捐款；3)继续开发常见实体肿瘤和血液恶性肿瘤的创新治疗计划；4)保持该机构知名的高水平数据质量和管理。这些目标将通过来自医学肿瘤学、放射肿瘤学、病理学和外科科学科的研究人员的密切互动来实现。范德比尔特调查员在众多的经社理事会疾病导向委员会和模式委员会中的存在，将促进范德比尔特调查和其他经社理事会机构之间的互动。范德比尔特癌症中心具备成功实施合作小组临床试验的所有必要要素，包括优秀的数据管理人员、开展这项工作的优秀门诊和住院设施以及长期参与合作小组的历史。

The principle objectives of this grant are to secure funding to support the clinical research activity of the Eastern Cooperative Oncology Group (ECOG) at Vanderbilt University Medical School, to facilital patient accrual to ECOG trials, and to expand the scientific and administrative contributions made to ECOG sponsored clinical trials and laboratory studies, 2) to further increase the scientific and administrative contributions to ECOG by Vanderbilt investigators, 3) to continue the development of innovative treatment programs for common solid tumors and hematologic malignancies, and 4) to maintain a high level of data quality and management for which the institution is known. These goals will be achieved through the close interaction of investigators from medical oncology, radiation oncology, pathology and the section of surgical sciences. The interactions between Vanderbilt investigations and other ECOG institutions will be facilitated by the presence of Vanderbilt investigators on numerous ECOG disease oriented committees and modality committees. The Vanderbilt Cancer Center has in place all the necessary elements for the successful execution of cooperative group clinical trials including an outstanding data management staff, excellent outpatient and inpatient facilities in which this work will be undertaken and a long history of cooperative group participation.